In the pharmaceutical industry, Dicyclomine Hydrochloride 10mg is classified as an antispasmodic and anticholinergic agent. As a pharmacist and manufacturer, I view this as a primary “Smooth Muscle Relaxant,” specifically designed to target the Gastrointestinal (GI) tract.
At your WHO-GMP facility in Mumbai, you likely manufacture this in 10mg and 20mg tablets, or as a syrup. It is a staple molecule for gastrointestinal health and is frequently used in Fixed-Dose Combinations (FDCs).
Primary Clinical Uses
The 10mg dose is the standard starting strength for managing functional bowel disorders:
Irritable Bowel Syndrome (IBS): It is the first-line treatment for the “crampy” abdominal pain and bloating associated with IBS.
Intestinal Colic: Relieves sudden, severe contractions of the intestines.
Gastrointestinal Spasms: Used to calm an overactive gut in various digestive upsets.
Biliary & Renal Colic: Sometimes used as an adjunct to manage spasms in the bile ducts or ureters.
Mechanism: The Muscarinic Blockade
Dicyclomine works through a dual-action mechanism to stop gut “spasms”:
Anticholinergic Action: It competitively blocks Acetylcholine at the Muscarinic ($M_3$) receptors located on the smooth muscle of the GI tract. Since acetylcholine is the chemical that tells muscles to contract, blocking it causes the muscles to relax.
Direct Antispasmodic Effect: At a cellular level, it has a direct effect on the smooth muscle fibers, independent of the nervous system, which helps reduce the frequency and intensity of peristaltic waves (the “squeezing” motion of the gut).
The Pharmacist’s “Patient Care” Tips
As you promote your firm on digital platforms, providing these technical insights builds professional trust:
The “Before Meal” Rule: For best results in IBS, the 10mg dose should be taken 30–60 minutes before meals. This prevents the “gastrocolic reflex” (cramping that happens immediately after eating).
Side Effect Profile: Because it is an anticholinergic, common side effects include dry mouth, blurred vision, and dizziness.
Contraindications: It must be avoided in patients with Glaucoma, Myasthenia Gravis, or severe ulcerative colitis.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai, Dicyclomine is a strategic “FDC” asset:
The “Mef-Spas” Strategy: One of the most successful B2B products in the Indian and African markets is the combination of Mefenamic Acid + Dicyclomine. Highlighting this combination on your marketplace as a “Period Pain Specialist” or “Dual-Action Spasmolytic” is a major growth strategy.
Syrup Formulations: For pediatric use (infantile colic), Dicyclomine syrups are high-volume items. Ensuring taste-masking and precise dosing in your 5mg/5ml or 10mg/5ml syrups is a key USP for export.
Stability & Packaging: Dicyclomine is relatively stable but sensitive to moisture. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb tropical regions.
Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international markets.